|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 261/08 | (2006.01) |
| A61K 31/42 | (2006.01) | ||
| A61P 31/04 | (2006.01) |
| (11) | Number of the document | 3468957 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17739696.7 |
| Date of filing the European patent application | 2017-06-12 | |
| (97) | Date of publication of the European application | 2019-04-17 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-26 |
| (46) | Date of publication of the claims translation | 2020-10-12 |
| (86) | Number | PCT/IB2017/053468 |
| Date | 2017-06-12 |
| (87) | Number | WO 2017/216705 |
| Date | 2017-12-21 |
| (30) | Number | Date | Country code |
| PCT/CN2016/0856 | 2016-06-14 | WO |
| (72) |
FU, Jiping, US
JIANG, Siyi, CN
KORDIKOWSKI, Andreas, CH
SWEENEY, Zachary Kevin, US
|
| (73) |
NOVARTIS AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | (R)-4-(5-(ciklopropiletil)izoksazol-3-il)-N-hidroksi-2-metil-2-(metilsulfonil)butanamido kristalinė forma kaip antibakterinis agentas |
| CRYSTALLINE FORM OF (R)-4-(5-(CYCLOPROPYLETHYNYL)ISOXAZOL-3-YL)-N-HYDROXY-2-METHYL-2-(METHYLSULFONYL)BUTANAMIDE AS AN ANTIBACTERIAL AGENT |
| Payment date | Validity (years) | Amount | |
| 2021-05-24 | 5 | 115.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-06-12 |